Molecular Testing in the Management of Pulmonary Nodules

Plasma-based proteomic screening, including but not limited to BDX-XL2 (Nodify XL2®), in individuals with undiagnosed pulmonary nodules detected by computed tomography is considered investigational.

Gene expression profiling on bronchial brushings, including but not limited to the Percepta® Genomic Sequencing Classifier, in individuals with indeterminate bronchoscopy results from undiagnosed pulmonary nodules is considered investigational.